arrow
A

Andrew McPherson

Memorial Sloan Kettering Cancer Center
H指数:40
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MMEJ repair of breaks at TA repeats maintains ecDNA and cancer fitness

TA重复序列处的断裂通过MMEJ修复维持了ecDNA和癌细胞适应性

Nature
IF48.5
2026-09-230
OAAI
A compendium of next-generation patient-derived models for diverse cancers

用于多种癌症的下一代患者来源模型汇编

Nature
IF48.5
2026-08-050
OA
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer

尿路上皮癌对HER2靶向抗体药物偶联物的敏感性决定因素

2025-12-200
OAAI
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology

实现从FFPE标本在临床肿瘤学中进行全基因组测序分析

2025-11-270
OAAI
Protocol for a multicentre randomised controlled trial of the Pharmacy Homeless Outreach Engagement Non-medical and Independent Prescriber (PHOENIx) intervention for people facing severe and multiple disadvantages

一项关于药房无家可归者外展参与非医疗和独立处方员(PHOENIx)干预措施的多中心随机对照试验方案,适用于面临严重多重不利处境的人群。

2025-11-210
PRE
Tracking clonal evolution during treatment in ovarian cancer using cell-free DNA

使用细胞游离DNA追踪卵巢癌治疗过程中的克隆进化

Nature
IF48.5
2025-10-010
OA
Ongoing genome doubling shapes evolvability and immunity in ovarian cancer

正在进行的基因组加倍塑造卵巢癌的进化和免疫力

Nature
IF48.5
2025-07-160
OA
FOXA2 promotes metastatic competence in small cell lung cancer

FOXA2促进小细胞肺癌的转移能力

2025-05-260
OAAI
Luminal breast epithelial cells of BRCA1 or BRCA2 mutation carriers and noncarriers harbor common breast cancer copy number alterations
2024-11-200
OAAI
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities (vol 8, 68, 2024)

富集HGSOC肿瘤上皮的蛋白质基因组分析确定预后特征和治疗弱点 (vol 8,68,2024)

2024-05-060
OAAI
Chromosomal instability causes epigenetic aberrations in cancer
2024-03-220
PRE
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities

富集HGSOC肿瘤上皮的蛋白质基因组分析确定预后特征和治疗脆弱性

2024-03-132
OAAI
Proteogenomic analysis of enriched tumor epithelium identifies prognostic signatures and an increased dependency of homologous recombination proficient cells on bmi1 in high grade serous ovarian cancer
2024-03-040
PRE